HPLC法检测红豆杉细胞培养物中的紫杉醇

在对紫杉醇和干扰紫杉醇测定的６种常见紫杉烷进行色谱化分离的基础上,建立了红豆杉细胞培养物中紫杉醇的高效相色谱检测方法。样品经提取后,在Ｋｒｏｍａｓｉｌ Ｃ１８柱上以乙腈：水为流动相进行梯度洗脱,于２２７ｎｍ处进行检测。紫杉醇在０．２μｇ／ｍｌ－２０μｇ／ｍｌ浓度范围内线性关系良好,经测定检测限为０．１μｇ／ｍｌ,检测精密度为３．４％,回收率为８８．４％。     

酪氨酸-铜体系电化学氧化行为的研究

在ｐＨ值３．９４的Ｂ－Ｒ缓冲溶液中,酪氨酸－铜络合物在玻碳电极出现氧化峰。用新极谱法测定,酪氨酸浓度在０．３μｇ／ｍｌ－３μｇ／ｍｌ范围内与氧化峰的２．５次微分值呈线性,检测下限０．２μｇ／ｍｌ。直接用于氨基酸药物样品的测定结果满意,并对酪氨酸－铜络合物的电化学氧化行为进行了研究。     

小鼠腺病毒单克隆抗体的研制及初步应用

应用杂交瘤技术获得４株分泌抗小鼠腺病毒（ＭｕｒｉｎｅＡｄｅｎｏｖｉｒｕｓＭＡｄ）单克隆抗体细胞株,并对其特性进行分析。经鉴定,它们所分泌的抗体类型均为ＩｇＭ,腹水效价为１０－３～１０－６。相对亲和力分别为０．１μｇ／ｍｌ（Ａ９）、０．６５μｇ／ｍｌ（Ｂｌ）、１２．５μｇ／ｍｌ（Ｇ４）和２３μｇ／ｍｌ（Ｄ４）。与其他１０种鼠源性病毒均无交叉反应,表明ＭｃＡｂ具有良好的特异性。单抗标记ＦＩＴＣ后用于人用鼠源性单抗制品及各种传代细胞和原代细胞中ＭＡｄ检测,获得良好的实验结果。     

天竺葵花清除自由基作用的研究

用化学发光法研究了天竺葵花粗担液对超氧阴离子自由基（Ｏ２）＾＝和羟自由基（ＯＨ）的清除作用,用分光不镀法研究了它对１,１－二苯基－２－苦肼基自由基（ＤＰＰＨ０的清除作用。结果表明,天竺葵花具有很强的清除自由基活性。其粗提物清除Ｏ２＾－分别为３．５μｇ／ｍｌ（红花）,３．０μｇ／ｍｌ（粉花）,１．６μｇ／ｍｌ（浅粉花）,与茶多酚（ＩＣ５０＝１．１μｇ／ｍｌ）相近,清除ＯＨ的ＩＣ５０分别为５．７μｇ／     

苦豆子游离氨基酸的成份测定

本文分析和鉴定了苦豆子中游离氨基酸的成份,测定出１６种游离氨基酸,总量为１６４．５２μｇ／１００ｍｇ,其中谷氨酸含量最高为４７．６８μｇ／１００ｍｇ,蛋氨酸含量最低为０．２０μｇ／１００ｍｇ,人体必须氨基酸有７种,占游离氨基酸总量的１７．３３％。     

乙二胺四醋酸二钠对蝮蛇抗栓酶毒性的影响

对照组小鼠腹腔注射蝮蛇抗栓酶０．１ｕ／１０ｇ,实验组同时再注射０．５％ＥＤＴＡ２Ｎａ溶液０．２５ｍｌ／１０ｇ,结果表明,死亡率各组间无差别（Ｐ＞０．０５）,但对照组动物脏器有出血现象,而实验组则无出血。     

消化道疾病患者胃微生态环境的改变

本文对５９例具有消化不良症状的患者做了内镜检查。取胃粘膜组织进行细菌的分离培养,镜检,测定胃液中的ｓＩｇＡ的含量及ｐＨ。结果表明,不同消化道疾病,胃的微生态环境会发生不同的改变。其中胃癌患者改变最明显,胃内微生物检出率高,ｐＨ均大于４,ｓＩｇＡ含量１４０．５７±３７．４５μｇ／ｍｌ,幽门螺杆菌（ＨＰ）的检出率为６６．７％;溃疡组,ＨＰ的检出率为７９．２％,其它微生物检出率较胃癌组低,ｓＩｇＡ含量１３３．８０±６５．８４μｇ／ｍｌ;胃炎组,微生物的检出率较低,ｓＩｇＡ含量７１．００±６０．３８μｇ／ｍｌ,ｐＨ大部分在２一４。     

虎奶菇深层发酵及氨基酸成份分析

本文采用不同发酵培养基培养３虎奶菇,结果表明,以玉米组成的培养基培养的虎奶甘、菌丝长势相对较好,总干重为０．８６３／１００ｍｌ培养液,且通过氨基酸分析,总氨基酸含量为１１．６８０２％,氨基酸总产量为０．１ｇ／１００ｍｌ培养液,必须氨基酸含量为７．１１６９％,占总氨基酸的６０．９３％,且检出的氨基酸中,以亮氨酸和异亮氨酸含量相对较高。麦芽糖组成的培养基培养的虎奶菇菌丝体总干重为０．６３８ｇ／１００ｍ     

中药板竹体外抗肠道致泻菌及消除耐药性的实验研究

本文就中药板竹体外面对肠道致泻菌的杀菌及消除耐药性作用进行了实验研究,结果表明：板竹对９８株受试菌均有一定的杀菌效果,从总体看,对弧菌科病原菌的杀菌作用比杆菌科的强,前者ＭＢＣ≤１２５００μｇ／ｍｌ,占９５。０％,ＭＢＣ≤１５６３μｇ／ｍｌ者占４５．０％;而后者分别占３４．５％,８．６％。     

多管藻R-藻红蛋白的激光光敏作用对体外培养的肿瘤细胞生存率的影响

用１００μｇ／ｍｌ藻红蛋白联合激光处理８１１３人口腔上皮癌细胞,ＭＴＴ比色法测定癌细胞存活率。实验表明,先用藻红蛋白处理再经波长为４８８ｎｍ,２５．６Ｊ／ｃｍ２氩离子激光辐照,细胞存活率为２５％;而单用藻红蛋白,单用激光组分别为４３％和１０７％。结果证明,藻红蛋白的光敏作用对体外培养的肿瘤细胞具有较强的杀伤作用。     

The Role of Caprylate Ligand Ion on the Stabilization of Human Serum Albumin

Sodium caprylate was added to a pharmaceutical-grade human serum albumin (HSA) to stabilize the product. In this study we have aimed to establish how caprylate ligand protects HSA from thermal degradation. The fatty acid stabilizer was first removed from commercial HSA by charcoal treatment. Cleaned HSA was made to 10% w/v in pH 7.4 buffered solutions and doped with sodium caprylate in serial concentrations up to 0.16 mmol/g-protein. These solutions as well as a commercial HSA, human serum, and enriched-albumin fraction were subjected to differential scanning calorimetry (DSC) within the temperature range of 37–90°C at a 5.0°C/min scanning rate. The globular size of the cleaned HSA solutions was measured by dynamic light scattering. The denaturing temperatures for albumin with sodium caprylate and a commercial one were significantly higher than for albumin only. It was found that the protein globules of cleaned HSA were not as stable as that of the native one due to aggregation, and the caprylate ion may reduce the aggregation by enlarging the globules’ electrical double layer. A rational approximation of the Lumry-Eyring protein denaturation model was used to treat DSC denaturing endotherms. The system turned from irreversible dominant Scheme: to reversible dominant Scheme: with the increase in caprylate concentration from null to ~0.08 mmol/g-protein. It was postulated that the caprylate ligand may decrease the rate of reversible unfolding as it binds to the IIIA domain which is prone to reversible unfolding/refolding and causes further difficulty for irreversible denaturation which, in turn, HSA can be stabilized.KEY WORDS: differential scanning calorimetry, human serum albumin, Lumry-Eyring model, protein denaturation, sodium caprylate     

Validation of a simple,rapid and cost effective method for the estimation of caprylic acid and sodium caprylate from biological products using NEFA-C kit

The method for the determination of caprylic acid and sodium caprylate from biological products was systematically validated using NEFA-C kit. The results obtained demonstrated that the kit method was simple, rapid, reliable, sensitive, reproducible and cost effective in comparison to the current methods i.e. colorimetric, High Performance Liquid Chromatography (HPLC) and Gas Chromatography (GC) methods. The assay exhibited excellent linearity, accuracy, precision and robustness. Mean recoveries ranged between 95 and 101.3% (n = 6). The proposed method was linear over the concentration range of 0.05–10 mM of caprylate with values of coefficient of regression being >0.99. Method showed sensitivity of 0.05 mM (7.21 μg/ml for caprylic acid and 8.31 μg/ml for sodium caprylate). The % Relative standard Deviation (%RSD) for intra and interprecision studies was less than 5%. In conclusion the validated method was successfully used in monitoring of processed bulk and final products generated during production of biological products thus laying emphasis on strict control of release criteria for biological products fractionated using caprylic acid.     

High-performance liquid chromatographic determination of 6-aminopenicillanic acid by postcolumn alkaline degradation

A high-performance liquid chromatographic method has been developed for the determination of 6-aminopenicillanic acid in amino acid mixtures and human serum. The separation of 6-aminopenicillanic acid was carried out on a C18 column using sodium heptylsulfonate or tetrabutylammonium bromide as an ion-pairing agent and methanol as an organic mobile phase modifier. Detection was based on a postcolumn reaction with sodium hydroxide, mercury(II) chloride, and ethylenediaminetetraacetic acid disodium salt followed by measurement of ultraviolet absorbance (at 300 nm) of the reaction product(s). The method is quantitative for 6-aminopenicillanic acid concentrations down to 0.1 microgram/ml in human serum samples with a 20-microliter injection. At a concentration of 2 micrograms/ml, the within- and between-run precisions (relative standard deviation) were 1.29-3.91% and 2.30%, respectively.     

Radioimmunoassay for zearalenone and zearalanol in human serum: production, properties, and use of porcine antibodies

To produce antigens susceptible to raise antibodies for resorcylic acid lactones, the 6'-carboxymethyloxime derivatives of zearalenone and zearalanone were bound to bovine serum albumin. Pigs could be immunized by using these antigens, the best titer in antibodies being obtained with the zearalenone antigen. The porcine antibodies were specific for the resorcylic acid lactones of structural resemblance with zearalenone. This specificity made the antibodies usable for a radioimmunoassay of zearalenone and zearalanol, which may be found in human and animal sera. The range of the assay was between 0.25 and 10 ng. The limit of detection was 5 ppb (5 ng/ml) in human serum.     

Radioimmunoassay for Zearalenone and Zearalanol in Human Serum: Production, Properties, and Use of Porcine Antibodies

To produce antigens susceptible to raise antibodies for resorcylic acid lactones, the 6′-carboxymethyloxime derivatives of zearalenone and zearalanone were bound to bovine serum albumin. Pigs could be immunized by using these antigens, the best titer in antibodies being obtained with the zearalenone antigen. The porcine antibodies were specific for the resorcylic acid lactones of structural resemblance with zearalenone. This specificity made the antibodies usable for a radioimmunoassay of zearalenone and zearalanol, which may be found in human and animal sera. The range of the assay was between 0.25 and 10 ng. The limit of detection was 5 ppb (5 ng/ml) in human serum.     

Improvement and validation of a liquid chromatographic method for the determination of levosulpiride in human serum and urine

A rapid, selective and highly sensitive reversed-phase high-performance liquid chromatography (HPLC) method was developed for the determination of levosulpiride, 5-(aminosulfonyl)-N-[(1-ethyl-2-pyrrolidinyl)methyl]-2-methoxy benzamide, in human serum and urine. The method involved the extraction with a dichloromethane followed by back-extraction into 0.025 M sulfuric acid. HPLC analysis was carried out using reversed-phase isocratic elution with a Luna C(18)(2) 5 microm column, a mobile phase of acetonitrile-0.01 M potassium hydrogen phosphate (30:70, v/v, adjusted to pH 8.5 with triethylamine), and a fluorescence detector with excitation at 300 nm and emission at 365 nm. The chromatograms showed good resolution and sensitivity and no interference of human serum and urine. The calibration curves were linear over the concentration range 0.25-200 ng/ml for serum and 0.2-20 microg/ml for urine with correlation coefficients greater than 0.997. Intra- and inter-day assay precision and accuracy fulfilled the international requirements. The mean absolute recovery for human serum was 89.8+/-3.7%. The lower limits of quantitation in human serum and urine were 0.25 ng/ml and 0.2 microg/ml, respectively, which were sensitive enough for pharmacokinetic studies. Stability studies showed that levosulpiride in human serum and urine was stable during storage, or during the assay procedure. This method was successfully applied to the study of pharmacokinetics of levosulpiride in human volunteers following a single oral administration of levosulpiride (25 mg) tablet.     

Analysis of olanzapine in human plasma utilizing reversed-phase high-performance liquid chromatography with electrochemical detection

A sensitive reversed-phase HPLC method for the analysis of olanzapine in human plasma is described. Isolation of olanzapine from plasma was accomplished by solid-phase extraction utilizing an ion-exchange/reversed-phase cartridge designed for basic drug extraction. The drug was subsequently separated by reversed-phase HPLC and monitored by electrochemical detection (ED). Electrochemical analysis was used to detect olanzapine due to its uniquely low oxidative potential. Ascorbic acid was added to prevent oxidation during extraction. The limit of quantitation for the assay was established at 0.25 ng/ml utilizing a 1-ml human plasma sample. The average inter-day accuracy was 96.6% with a average precision (%C.V.) of 3.22% over the concentration range of 0.25 to 100 ng/ml. This method was applied to human plasma samples from human clinical trials with olanzapine. The HPLC-ED method compared favorably with a negative chemical ionization GC-MS method previously utilized for analysis of olanzapine in human plasma.     

Flow injection analysis-Rayleigh light scattering detection for online determination of protein in human serum sample

A flow injection analysis (FIA) system combined with Rayleigh light scattering (RLS) detection is developed for the sensitive and rapid determination of protein concentration in human serum sample. This method is based on the weak intensity of RLS of Eriochrome Black T (EBT, 2-hydroxy-1-(1-hydroxy-2-naphthylazo)-6-nitronaphthalene-4-sulfonic acid sodium salt), which can be enhanced by the addition of protein in weakly acidic solution. The effects of pH and interfering species on the determination of protein were examined. Calibrations for protein, based on RLS intensity, were linear in the concentration ranges of 7-36 microg/ml for human serum album (HSA) and 8-44 microg/ml for bovine serum album (BSA). The detection limits of the method were found to be 0.882 and 2.507 microg/ml for HSA and BSA, respectively. A relative standard deviation of 0.76% (n=5) was obtained with 20 microg/ml HSA standard solution. The FIA-RLS method was more stable than the general RLS method, and the average RSD value of FIA-RLS was less than that of the general RLS. The sample rate was determined to be 90 samples per hour.     

牛血清蛋白酶联免疫检测试剂盒的研制及验证

为研制酶联免疫试剂盒以检测病毒性疫苗中残余牛血清蛋白(BSP)含量,制备高效价高纯度的兔抗BSP多克隆抗体作为包被抗体和酶标抗体,建立了ELISA双抗体夹心法并组建试剂盒,通过标准剂量曲线可对样品中所含BSP、BSA及B-IgG进行定量,经验证该方法标准曲线线性范围内r≥0.98,对BSP的检测限量为3ng/ml;分别检测5、10、20ng/ml含量的BSP时,试验内(n=12)和试验间(n=3)测定的变异系数在3.71%到7.29%之间,回收率在93.4%~106.3%,未见该方法与人血清白蛋白、卵清蛋白以及疫苗复合保护剂之间有交叉反应。该法敏感度高,准确性、重复性和稳定性好,可用于疫苗牛血清残余蛋白的质量控制。     

Effects of fluorinated and hydrogenated surfactants on human serum albumin at different pHs

Complexation between human serum albumin (HSA) and two different surfactants, one fully fluorinated (sodium perfluorooctanoate, SPFO) and one fully hydrogenated (sodium caprylate, SO), was studied using zeta-potential measurements and difference spectroscopy. The study was carried out at three different pHs, 3.2, 6.7, and 10.0. The spectroscopy study was performed at pHs 6.7 and 10.0, given that at pH 3.2 high turbidity was observed in the wide range of surfactant concentrations. The results were interpreted in terms of the electrostatic and hydrophobic contributions to the stability of the different phases formed in the water-surfactant-HSA system. Solutions and precipitates were observed in the concentration range investigated in more detail. Using Pace methods, the thermodynamic values of the surfactant-induced conformational changes in HSA were determined for sodium perfluorooctanoate in the concentration range 2-12 mmol dm(-3) at pH 6.7 and 5-22 mmol dm(-3) at pH 10.0. Electrophoretic measurements were used to characterize surfactant adsorption by determining the number of molecules adsorbed on the surface of HSA and the Gibbs energy of adsorption. Finally, the interactions between human serum albumin and other anionic surfactants studied by other authors were compared with those observed in the present work.